No insider purchase over the last 90 days. The latest was filed 01 Apr 2024.
Azitra Inc is a listed company. Filings by its managers are published through SEC (Form 4). Between 18 October 2025 and 18 October 2026, 1 insider published 1 filing.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Across the 5,458 companies tracked on its exchange, the median is 22 filings; at 1 filing, this issuer sits below that mark. Over the whole record (from 2023), the tally stands at 4 purchases and 2 sales.
No insider has bought Azitra Inc shares on the open market in the past twelve months.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
12 of 12 declarations
Azitra Inc is a company listed on the XNAS market. It focuses on developing innovative treatments for skin diseases.
Purchases our model currently ranks for the recommendations list.
All recommendations